|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1110 Vermont Ave NW |
Address2 | Suite 300 |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 31634-12
|
||||||||
|
6. House ID# 316750000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Georgeanne Usova |
Date | 10/20/2023 3:42:52 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024 (S. 2438/H.R. 4665)
Financial Services and General Government Appropriations Act, 2024 (S.2309/H.R.4664)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 (S. 2624/H.R.5894)
Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill, 2024 (S.2127/H.R.4366)
Homeland Security Appropriations Bill, 2024 (S.2625/H.R.4367)
Department of Defense Appropriations Act, 2024 (H.R. 4365/S.2587)
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024 (S.2321/H.R.5893)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 (H.R.4368/S.2131)
The Continuing Appropriations Act (H.R. 5860)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Caitlin |
Horrigan |
|
|
|
Christina |
Krysinski |
|
|
|
Nina |
Esperanza Serrianne |
|
|
|
Jocelyn |
Irene Collins |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
A bill to amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to permit enrollees to obtain a 365-day supply of contraceptives. (S. 2427/H.R. 4816)
Reproductive Health Care Accessibility Act (S. 4764/H.R. 9040)
Child Marriage Prevention Act of 2023
The Orally Taken Contraception Act (H.R. 4626)
Right to Contraception Act (S. 4557)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Nina |
Esperanza Serrianne |
|
|
|
Caitlin |
Horrigan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Global HER Act (H.R. 1838/S. 1098)
Abortion is Health Care Everywhere Act (H.R. 1723/S. 929)
Support UNFPA Funding Act (H.R. 4166)
PEPFAR Reauthorization (not yet introduced)
Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2023 (H.R. 5856)
Expressing support for the recognition of September 26, 2023, as "World Contraception Day" and expressing the sense of the House of Representatives regarding global and domestic access to contraception. (H.Con Res 68)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Caitlin |
Horrigan |
|
|
|
Christina |
Krysinski |
|
|
|
Nina |
Esperanza Serrianne |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Judiciary Act (H.R. 3422)
Supreme Court Biennial Appointments and Term Limits Act of 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Nina |
Esperanza Serrianne |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Pharmacy Benefit Manager Reform Act (S. 1339)
The Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023 (S. 3561)
Lower Costs, More Transparency Act (H.R. 5378)
To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program (H.R. 3290)
340B Accountability Act of 2023 (S. 1133)
Pharmacy Benefits Manager Accountability Act (H.R. 2679)
To amend title XXVII of the Public Health Service Act to limit cost sharing for prenatal services in certain circumstances.
Black Maternal Health Momnibus Act (H.R. 3305/S. 1606)
Modernizing and Ensurging PBM Accountability Act (MEPA Act)
Medicare PBM Accountability Act (Discussion Draft)
Senate Bi-Partisan 340B RFI
National Drug Rebate Clearinghouse Proposal
Pandemic and All Hazards Preparedness Act (PAHPA) (S. 2333)
Bipartisan Primary Care and Health Workforce Act (S. 2840)
Jeanette Acosta Invest in Womens Health Act (not yet introduced)
Health Equity and Accountability Act (not yet introduced)
Caring for Grieving Families Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Jocelyn |
Irene Collins |
|
|
|
Nina |
Esperanza Serrianne |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
National Defense Authorization Act for Fiscal Year 2024 (H.R. 2670)
Jackson (TX) amendment 5 to H.R. 2670, National Defense Authorization Act, FY2024 (H. Amdt. 222)
Rosendale (MT) amendment 10 to H.R. 2670, National Defense Authorization Act, FY2024 (H. Amdt. 223)
Norman (SC) amendment 20 to H.R. 2670, National Defense Authorization Act, FY2024 (H. Amdt. 224)
"Escobar Log 3611r5 to H.R. 2670, National Defense Authorization Act, FY2024 (would eliminate cost-sharing for any eligible TRICARE beneficiary for contraceptives acquired through retail pharmacies and the national mail order pharmacy for one calendar year.)"
Access to Contraception for Servicemembers and Dependents Act of 2023 (S. 1527)
Protecting Service Members and Military Families Access to Reproductive Care Act of 2023 (S. 1610)
National Defense Authorization Act for Fiscal Year 2024 (S. 2226)
Military Access to Reproductive Care and Health (MARCH) for Military Servicemembers Act (H.R. 4418)
Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act of 2023 (S.822)
"Expressing support for the personnel policies the Department of Defense issued on February 16, 2023 to ensure service members and their families can access necessary reproductive health care, including access to abortion and fertility care." (not yet introduced)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Nina |
Esperanza Serrianne |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Health Equity and Access under the Law for Immigrant Families Act of 2023 (H.R. 5008/S. 2646)
Stop Shackling and Detaining Pregnant Women Act (not yet introduced)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Equal Access to Reproductive Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Georgeanne |
Usova |
|
|
|
Nina |
Esperanza Serrianne |
|
|
|
Karen |
Stone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |